Skip to main content
Levitee Labs Inc. logo

Levitee Labs Inc. — Investor Relations & Filings

Ticker · LVT ISIN · CA5274241051 LEI · 254900LJ1KD4EB3C0N68 CSE Human health and social work activities
Filings indexed 77 across all filing types
Latest filing 2022-09-17 Capital/Financing Update
Country CA Canada
Listing CSE LVT

About Levitee Labs Inc.

http://leviteelabs.com/

Levitee Labs Inc. is an integrative wellness company focused on redefining mental healthcare and addiction treatment through preventative, restorative, and transformative methods. The company operates a diversified portfolio of healthcare and wellness assets, specializing in the delivery of evidence-based novel psychedelic therapies. Levitee Labs also develops and sells functional mushroom products, including high-potency extract nutraceuticals, through operating units such as Monk-E Nutraceuticals and Sporeo Supply. Its core strategy involves the centralization and accretive acquisition of cash-flowing integrative wellness assets.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the sale of assets (Earth Circle) and the terms of a credit facility amendment with RiverFort Global Capital. It details the transaction terms, financing agreement amendments, share issuances, and warrants. There are no financial statements, quarterly or annual results, or detailed financial analysis. The content focuses on financing and capital structure updates, including loan agreements and share issuance terms. It is not an earnings release, annual report, or audit report. The document is not a regulatory filing or report publication announcement but a substantive update on financing and capital activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-09-17 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-08-30 English
Interim MD&A - English.pdf
Regulatory Filings
2022-08-30 English
News release - English.pdf
Regulatory Filings
2022-06-21 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-05-31 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-05-31 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.